Milestone Pharmaceuticals: Fourth Quarter Earnings Overview

Milestone Pharmaceuticals Reports Fourth Quarter Financial Results

Milestone Pharmaceuticals Inc., headquartered in Montreal, announced a net loss of $17.4 million for its fourth quarter.

The company stated that this equates to a loss of 16 cents per share.

These figures were better than anticipated by analysts, as a consensus of three experts polled by Zacks Investment Research had predicted a loss of 18 cents per share.

During the quarter, the biotech firm generated $1.5 million in revenue.

Looking at the full year, Milestone Pharmaceuticals recorded a total loss of $63.1 million, or 75 cents per share, with annual revenue also totaling $1.5 million.